Showing 1 - 10 of 26
The WTO has just finished two and one half years of negotiations on the TRIPS Agreement and Public Health, with an additional tranche of negotiations scheduled to commence soon. These negotiations have been extraordinarily instructive on the subject of trade diplomacy and the means by which ends...
Persistent link: https://www.econbiz.de/10014173855
The wheel of the global medicines supply market is broken, but proposals for fixing it are at very early stages. The patent is an instrument designed to aggregate production capital, and for some product sectors the patent may be the best means for promoting the introduction of new products. But...
Persistent link: https://www.econbiz.de/10014173905
This article addresses NAFTA's environment-related dispute settlement mechanisms and how these might serve as a prototype for other regional integration efforts. The article focuses on a few critical issues with respect to NAFTA's environment-related dispute mechanisms. These are: (1) whether...
Persistent link: https://www.econbiz.de/10014174570
This Essay considers one aspect of the regional integration phenomenon, examining it in the specific context of its present and potential impact on regimes for the protection of the environment. This Essay will consider whether the European Community model for protection of the environment may...
Persistent link: https://www.econbiz.de/10014174571
This report identifies and analyses trends in the local production of medicines in developing countries and related technology transfer. The objective is to assist the World Health Organization (WHO) in its support for Member States in implementing the global strategy and plan of action on...
Persistent link: https://www.econbiz.de/10014174976
In the decade since the Doha Declaration was adopted, significant progress has been made in addressing problems associated with innovation and access to medicines, including through expanded financial support for procurement and distribution of treatments and vaccines and the establishment of...
Persistent link: https://www.econbiz.de/10014175331
The Doha Declaration on the TRIPS Agreement and Public Health (in its Paragraph 6) recognized that developing countries with insufficient or no manufacturing capacity in the pharmaceutical sector could face difficulties in making effective use of compulsory licensing under the TRIPS Agreement....
Persistent link: https://www.econbiz.de/10014178461
During the past several years, the United States has concluded a substantial number of bilateral and regional free trade agreements (hereinafter “FTAs”), largely with developing countries. Each of those FTAs includes substantial commitments in the field of intellectual property rights (IPRs)...
Persistent link: https://www.econbiz.de/10014178512
The objectives of this study were: (a) to explore the possibilities of developing a harmonized, pro-public health regional (Caribbean) IP regulation and drug policy (to include generic drugs) framework; (b) to make recommendations on the promulgation/up-dating of IP legislation and regulation...
Persistent link: https://www.econbiz.de/10014178707
New information technologies enable individuals in disparate locations to conduct cutting-edge research, to move that research into the development and testing of new medicines, to manufacture high-quality products, and to move those products to patients around the world. Conceptually, the world...
Persistent link: https://www.econbiz.de/10014041752